Company intelligence
Numa Wayne Capital Advisors
Investment bankers to healthy living and healthcare companies.
About Numa Wayne Capital Advisors
At Numa Wayne Capital Advisors, we provide world-class financial and strategic advisory services to lower middle-market companies with enterprise values ranging from $10 million to $200 million. Our expertise includes M&A advisory, capital raising, valuations, and strategic advisory, tailored to meet the unique needs of privately held businesses. We specialize in the Healthy Living and Healthcare industries, partnering with companies offering products, services, and technologies in areas such as fitness, sports, wellness, healthy nutrition, digital health, medical devices, pharma, and biotech. What We Do: • M&A Advisory: We guide business owners through sell-side and buy- side transactions, maximizing value and ensuring successful transitions. • Capital Raising: Specializing in debt capital solutions, we help businesses secure funding to drive growth, manage liquidity, or restructure operations. • Valuations: We deliver comprehensive assessments to determine fair market value and support strategic decision-making. • Strategic Advisory: We facilitate joint ventures, strategic alliances, and restructurings to enhance growth and operational efficiency. Why Choose Us: • Wall Street Expertise for Main Street Businesses: Decades of experience in mergers and acquisitions and corporate finance. • Client-Centric Approach: We prioritize trust, transparency, and tailored solutions that align with your goals. • Proven Results: A track record of delivering creative deal structures and exceptional outcomes. Our mission is to help business owners unlock value, navigate complex financial challenges, and achieve their strategic goals. At Numa Wayne Capital Advisors, we’re passionate about empowering businesses to thrive in a competitive marketplace. Let’s Build Your Future Together. Contact us to explore how we can support your success.
Verified activity
Signals from Numa Wayne Capital Advisors
5 published signals
Capital & Finance
Numa Wayne Capital Advisors reported that Aritra raised a $25 million Series B led by Definement Partners, bringing total funding to $51 million.
Reported by Kahlil Reid
Capital & Finance
Numa Wayne Capital Advisors notes that the FDA closed out a year-old warning letter over WHOOP’s Blood Pressure Insights feature after WHOOP modified the product and labeling to fit the agency’s updated general-wellness framework.
Reported by Kahlil Reid
Capital & Finance
Numa Wayne Capital Advisors is conducting an investigational blood-pressure study and expects a fully developed algorithm to be regulated as a medical device if cleared or approved by the FDA.
Reported by Kahlil Reid
Capital & Finance
Numa Wayne Capital Advisors filed for an IPO for Oura after generating $1.21 billion of revenue and $60.8 million of net income in the nine months ended June 30.
Reported by Kahlil Reid
Capital & Finance
Numa Wayne Capital Advisors announced that Scan.com raised $220 million in financing after doubling revenue to more than a $165 million annualized run rate.
Reported by Kahlil Reid